Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Subsequent Event Risk in Individuals With Established Coronary Heart Disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Genetic Determinants of Electrocardiographic P-Wave Duration and Relation to Atrial Fibrillation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Randomization of Left-right Asymmetry and Congenital Heart Defects: The Role of DNAH5 in Humans and Mice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. High-resolution Regulatory Maps Connect Vascular Risk Variants to Disease Related Pathways

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Risk Factors for Morbidity and Mortality Following Hospitalization for Pericarditis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Incidence of infective endocarditis during the coronavirus disease 2019 pandemic: A nationwide study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Mortality and return to work in patients transported by emergency ambulance after involvement in a traffic accident

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Riyaz S Patel
  • Vinicius Tragante
  • Amand F Schmidt
  • Raymond O McCubrey
  • Michael V Holmes
  • Laurence J Howe
  • Kenan Direk
  • Axel Åkerblom
  • Karin Leander
  • Salim S Virani
  • Karol A Kaminski
  • Jochen D Muehlschlegel
  • Hooman Allayee
  • Peter Almgren
  • Maris Alver
  • Ekaterina V Baranova
  • Hassan Behloui
  • Bram Boeckx
  • Peter S Braund
  • Lutz P Breitling
  • Graciela Delgado
  • Nubia E Duarte
  • Marie-Pierre Dubé
  • Line Dufresne
  • Niclas Eriksson
  • Luisa Foco
  • Markus Scholz
  • Crystel M Gijsberts
  • Charlotte Glinge
  • Yan Gong
  • Jaana Hartiala
  • Mahyar Heydarpour
  • Jaroslav A Hubacek
  • Marcus Kleber
  • Daniel Kofink
  • Salma Kotti
  • Pekka Kuukasjärvi
  • Vei-Vei Lee
  • Andreas Leiherer
  • Petra A Lenzini
  • Daniel Levin
  • Leo-Pekka Lyytikäinen
  • Nicola Martinelli
  • Ute Mons
  • Christopher P Nelson
  • Kjell Nikus
  • Anna P Pilbrow
  • Rafal Ploski
  • Yan V Sun
  • Michael W T Tanck
  • W H Wilson Tang
  • Stella Trompet
  • Sander W van der Laan
  • Jessica Van Setten
  • Ragnar O Vilmundarson
  • Chiara Viviani Anselmi
  • Efthymia Vlachopoulou
  • Lawien Al Ali
  • Eric Boerwinkle
  • Carlo Briguori
  • John F Carlquist
  • Kathryn F Carruthers
  • Gavino Casu
  • John Deanfield
  • Panos Deloukas
  • Frank Dudbridge
  • Thomas Engstrøm
  • Natalie Fitzpatrick
  • Kim Fox
  • Bruna Gigante
  • Stefan James
  • Marja-Liisa Lokki
  • Paulo A Lotufo
  • Nicola Marziliano
  • Ify R Mordi
  • Joseph B Muhlestein
  • Christopher Newton-Cheh
  • Jan Pitha
  • Christoph H Saely
  • Ayman Samman-Tahhan
  • Pratik B Sandesara
  • Andrej Teren
  • Adam Timmis
  • Frans Van de Werf
  • Els Wauters
  • Arthur A M Wilde
  • Ian Ford
  • David J Stott
  • Ale Algra
  • Maria G Andreassi
  • Diego Ardissino
  • Benoit J Arsenault
  • Christie M Ballantyne
  • Thomas O Bergmeijer
  • Connie R Bezzina
  • Simon C Body
  • Eric H Boersma
  • Peter Bogaty
  • Michiel L Bots
  • Hermann Brenner
  • Jasper J Brugts
  • Ralph Burkhardt
  • Clara Carpeggiani
  • Gianluigi Condorelli
  • Rhonda M Cooper-DeHoff
  • Sharon Cresci
  • Nicolas Danchin
  • Ulf de Faire
  • Robert N Doughty
  • Heinz Drexel
  • James C Engert
  • Keith A A Fox
  • Domenico Girelli
  • Diederick E Grobbee
  • Emil Hagström
  • Stanley L Hazen
  • Claes Held
  • Harry Hemingway
  • Imo E Hoefer
  • G Kees Hovingh
  • Reza Jabbari
  • Julie A Johnson
  • J Wouter Jukema
  • Marcin P Kaczor
  • Mika Kähönen
  • Jiri Kettner
  • Marek Kiliszek
  • Olaf H Klungel
  • Bo Lagerqvist
  • Diether Lambrechts
  • Jari O Laurikka
  • Terho Lehtimäki
  • Daniel Lindholm
  • B K Mahmoodi
  • Anke H Maitland-van der Zee
  • Ruth McPherson
  • Olle Melander
  • Andres Metspalu
  • Anna Niemcunowicz-Janica
  • Oliviero Olivieri
  • Grzegorz Opolski
  • Colin N Palmer
  • Gerard Pasterkamp
  • Carl J Pepine
  • Alexandre C Pereira
  • Louise Pilote
  • Arshed A Quyyumi
  • A Mark Richards
  • Marek Sanak
  • Agneta Siegbahn
  • Tabassome Simon
  • Juha Sinisalo
  • J Gustav Smith
  • John A Spertus
  • Steen Stender
  • Alexandre F R Stewart
  • Wojciech Szczeklik
  • Anna Szpakowicz
  • Jean-Claude Tardif
  • Jurriën M Ten Berg
  • Jacob Tfelt-Hansen
  • George Thanassoulis
  • Joachim Thiery
  • Christian Torp-Pedersen
  • Yolanda van der Graaf
  • Frank L J Visseren
  • Johannes Waltenberger
  • Peter E Weeke
  • Pim Van der Harst
  • Chim C Lang
  • Naveed Sattar
  • Vicky A Cameron
  • Jeffrey L Anderson
  • James M Brophy
  • Guillaume Pare
  • Benjamin D Horne
  • Winfried März
  • Lars Wallentin
  • Nilesh J Samani
  • Aroon D Hingorani
  • Folkert W Asselbergs
Vis graf over relationer

BACKGROUND: The Genetics of Subsequent Coronary Heart Disease (GENIUS-CHD) consortium was established to facilitate discovery and validation of genetic variants and biomarkers for risk of subsequent CHD events, in individuals with established CHD.

METHODS: The consortium currently includes 57 studies from 18 countries, recruiting 185 614 participants with either acute coronary syndrome, stable CHD, or a mixture of both at baseline. All studies collected biological samples and followed-up study participants prospectively for subsequent events.

RESULTS: Enrollment into the individual studies took place between 1985 to present day with a duration of follow-up ranging from 9 months to 15 years. Within each study, participants with CHD are predominantly of self-reported European descent (38%-100%), mostly male (44%-91%) with mean ages at recruitment ranging from 40 to 75 years. Initial feasibility analyses, using a federated analysis approach, yielded expected associations between age (hazard ratio, 1.15; 95% CI, 1.14-1.16) per 5-year increase, male sex (hazard ratio, 1.17; 95% CI, 1.13-1.21) and smoking (hazard ratio, 1.43; 95% CI, 1.35-1.51) with risk of subsequent CHD death or myocardial infarction and differing associations with other individual and composite cardiovascular endpoints.

CONCLUSIONS: GENIUS-CHD is a global collaboration seeking to elucidate genetic and nongenetic determinants of subsequent event risk in individuals with established CHD, to improve residual risk prediction and identify novel drug targets for secondary prevention. Initial analyses demonstrate the feasibility and reliability of a federated analysis approach. The consortium now plans to initiate and test novel hypotheses as well as supporting replication and validation analyses for other investigators.

OriginalsprogEngelsk
TidsskriftCirculation. Genomic and precision medicine
Vol/bind12
Udgave nummer4
Sider (fra-til)e002470
ISSN2574-8300
DOI
StatusUdgivet - apr. 2019

ID: 59123651